Breast cancer research and treatment
-
Breast Cancer Res. Treat. · Mar 2001
Randomized Controlled Trial Clinical TrialMetastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
The study evaluates the therapeutic efficacy of Strontium-89-chloride (89Sr) and 186Re-1,1-hydroxyethylidene diphosphonate (186Re-HEDP) in the palliation of painful bone metastases from breast cancer. ⋯ Both 89Sr and 186Re-HEDP are effective and safe in bone pain palliation in breast cancer with the latter showing a significantly faster onset of pain relief.